Please login to the form below
J&J puts pressure on rivals with new Erleada okay in prostate cancer
FDA previously granted priority review in this indication
Takeda’s HAE drug Takhzyro backed by NICE
New treatment option for rare, hereditary disease
Roche wins FDA breakthrough for Gazyva in lupus nephritis
Drug originally approved as a lymphoma treatment
FDA starts speedy review of Merck’s Ebola vaccine
First company to file for approval in the US
J&J's Tremfya filed for approval in US for psoriatic arthritis
Seeking share of increasingly competitive psoriasis market
Aimmune gets FDA panel backing for peanut allergy therapy
Step closer to becoming first approved treatment
FDA fast-tracks AstraZeneca’s Farxiga in heart failure
Races to become first-in-class
AbbVie/Allergan's merger faces public opposition
Advocacy groups and unions in the US express concerns
‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’
Brexit means pharma must review its intellectual property rights across Europe
-
Moving timesContinuity and stability are vital when it comes to the EMA's relocation when it leaves London
-
SMC gives green light for Amgen’s KyprolisThe committee also gives verdict on three other products
-
NICE approves BioMarin’s Brineura after initial setbackFirst treatment for rare disease
-
Novartis’ CAR-T Kymriah scores SMC approvalWill now be available on NHS across the UK
-
Boehringer bags FDA OK for Ofev in rare lung disease ILDFirst drug approved for condition
-
Novartis’ lung cancer drug wins FDA Breakthrough Therapy DesignationProvides hope for new treatment of rare cancer
-
Roche scores EU approval twice for Tecentriq in lung cancerCarves out space in a market dominated by MSD's Keytruda
-
Genentech agrees trade secret theft settlement with Taiwan’s JHLThree ex-Genetech workers pleaded not guilty to criminal theft charges
-
MSD’s Keytruda catches up in kidney cancerCombination therapy approved in EU for all risk groups
Latest regulatory appointments
-
Professor Carole Longson moves from NICE to the ABPIShe joins the UK pharma body as its chief scientific officer
-
MedTech Europe appoints new board of directors
Chair of the board Michelle Brennan is among those newly elected
-
Greg Perry joins IFPMA as assistant director generalWill move to the global industry body from the Medicines Patent Pool
-
AVEO appoints Nikhil Mehta as its senior VP, regulatory and quality assurance
He joins the biopharma from Tang Capital Management
-
IFPMA names new communications director
Helen Gallagher joins the association from Ferring Pharmaceuticals
Featured jobs
- Account Manager – Healthcare advertising
-
Salary TBC
-
Senior Medical Writer
-
Competitive salary plus benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Client Services Director- Flexible Working
-
Negotiable
-
Events Executive
-
DOE
-
Account Director – UK Office
-
Excellent salary and benefits
Subscribe to our email news alerts
- Novartis eyes potential new indication for Cosentyx
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- Envision Pharma Group relocates to support expansion
- Biogen loses another pipeline drug to toxicity concerns
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Half of European cancer drug trials ‘biased’, says BMJ
PMHub
3 Monkeys Zeno
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...
Latest intelligence
- Report: Customer experience, shaping digital healthcare
- In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
- Encouraging signs in biomarker R&D
- The cancer immunotherapy firms ramping-up biomarker R&D...
- Programmatic methodology and why you should be using it
- What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Quick links
Infographics
